Clinical Trial Update: Assessment of the Effects on Barrier Impairment, Clinical Features and Bacterial Colonization of Topical Formulations in Patients With Atopic Eczema; a Phase IIa, Single-center, Randomized, Observer-blind Study [Phase 1, Phase 2]

View source ↗

Summary

Phase I/IIa randomized, observer-blind study evaluating topical formulations for barrier impairment, clinical features, and bacterial colonization in atopic der…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Snippet

Sponsor: Moberg Pharma AB | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: COMPLETED